---
uid: Z-001-1158
type: zettel
title: Pathway and Network Analysis — Metabolomics Interpretation
domain: 001
tags: [zettel, pathway-analysis, network-analysis, metabolomics, kegg, metaboanalyst]
parent-moc: 
extraction-date: 2026-03-09
source-litnote: "[[LitNote_Metabolomics_Data_Processing_L-001-0619]]"
status: conscious
---

# Pathway and Network Analysis —  Interpretation

## Overview

Pathway analysis maps significant metabolites to biological pathways, while network analysis reveals metabolic interactions and hub metabolites. These methods transform statistical findings into biological understanding.

---

## Pathway Analysis

### Goal
Connect differential metabolites to known metabolic pathways for biological interpretation.

### Types of Pathway Analysis

#### 1. Over-Representation Analysis (ORA)
**Method:**
- Identify significant metabolites (p < 0.05)
- Test if pathway contains more significant hits than expected by chance
- Fisher's exact test or hypergeometric test

**Input:** List of significant metabolites
**Output:** Enriched pathways (p-values)

#### 2. Pathway Topology Analysis
**Method:**
- Accounts for pathway structure
- Considers metabolite positions (upstream/downstream)
- Impact factor calculation

**Tools:**
- MetaboAnalyst (Impact analysis)
- KEGG mapper
- MetPA

#### 3. Joint Pathway Analysis (Multi-omics)
**Method:** Integrate metabolomics with transcriptomics/proteomics
**Advantage:** Systems-level understanding
**Tools:** IMPaLA, Paintomics, XCMS Online

---

## Key Databases

### KEGG (Kyoto Encyclopedia of Genes and Genomes)
**Coverage:**
- 500+ metabolic pathways
- 20,000+ compounds
- Cross-species (human, mouse, rat)

**Access:** kegg.jp, KEGGREST (R)

### MetaboAnalyst Pathway Library
**Features:**
- Curated human pathways
- Integrated statistical testing
- Visualization tools

### SMPDB (Small Molecule Pathway Database)
**Focus:** Disease-specific pathways
**Use case:** Clinical metabolomics

---

## Network Analysis

### Metabolic Networks
**Nodes:** Metabolites
**Edges:** Biochemical reactions (enzymes)

### Analysis Types

#### 1. Correlation Networks
**Method:** Pairwise correlations between metabolites
**Interpretation:**
- Positive correlation: Same pathway or co-regulated
- Negative correlation: Opposing pathways

**Tools:**
- WGCNA (Weighted Gene Co-expression Network Analysis)
- Cytoscape
- R (igraph, corrr)

#### 2. Knowledge-Based Networks
**Method:** Map to known metabolic networks (KEGG, Reactome)
**Advantage:** Biological context
**Tools:** MetScape, Pathvisio

### Hub Metabolites
**Definition:** Highly connected nodes in network
**Significance:** Potential regulatory points, therapeutic targets

**METHAP Application:**
- Identify hub metabolites differentiating IR vs healthy
- Prioritize for intervention targeting

---

## METHAP Interpretation Strategy

### Step 1: Differential Metabolite Identification
- Statistical testing (t-test, Wilcoxon)
- FDR correction (Benjamini-Hochberg)
- Fold-change calculation

### Step 2: Pathway Enrichment
**Input:** Top 20-50 significant metabolites
**Analysis:**
- Over-representation in KEGG pathways
- Topology analysis (MetaboAnalyst)
- Disease pathway mapping (SMPDB)

### Step 3: Network Construction
**Correlation network:**
- Threshold: |r| > 0.7
- Visualize in Cytoscape
- Identify modules/clusters

### Step 4: Integration
**Multi-omics (if available):**
- Transcriptomics + Metabolomics
- Proteomics + Metabolomics
**Tools:** IMPaLA, MOFA

---

## Key Pathways in  Resistance

### Expected Enrichments
| Pathway | Expected Change | Key Metabolites |
|---------|----------------|-----------------|
| **Glycolysis** | Increased | Pyruvate, lactate |
| **Fatty acid oxidation** | Decreased | Acylcarnitines, dicarboxylic acids |
| **TCA cycle** | Altered | Citrate, α-ketoglutarate |
| **Ketogenesis** | Suppressed | β-hydroxybutyrate, acetoacetate |
| **Omega-3 ** | Decreased | EPA, DHA |

---

## Software Tools

| Tool | Function | Platform |
|------|----------|----------|
| **MetaboAnalyst** | Pathway analysis, statistics | Web/R |
| **KEGG Mapper** | Pathway visualization | Web |
| **Cytoscape** | Network visualization | Desktop |
| **MetScape** | Metabolite annotation | Cytoscape plugin |
| **Pathvisio** | Pathway drawing/analysis | Desktop |

---

## Interpretation Best Practices

### 1. Context Matters
- Consider diet, fasting state, medications
- Compare to literature findings
- Validate with orthogonal methods

### 2. Statistical Rigor
- FDR correction mandatory
- Effect size > p-value
- Cross-validation of pathways

### 3. Biological Plausibility
- Does pathway make physiological sense?
- Are key enzymes regulated?
- Consistent with other omics?

---

## Related

- [[Metabolomics_Preprocessing_Quality_Control_[Z-001-1156].md]]
- [[Normalization_Scaling_Metabolomics_Data_[Z-001-1157].md]]
- [[METHAP_Intervention_Protocol_Diet_Supplements_[Z-001-1142].md]]

---

*Source: [[LitNote_Metabolomics_Data_Processing_L-001-0619]] | 2026-03-09*

## RELATED FILES
- [[Biomarkers/Methylation_Family_[B-004-0001]|Biomarker Family]]
- [[Biomarkers/Metabolic_IR_Family_[B-005-0001]|Biomarker Family]]
